Compare GLW & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GLW | BSX |
|---|---|---|
| Founded | 1851 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.7B | 93.4B |
| IPO Year | 2008 | 2010 |
| Metric | GLW | BSX |
|---|---|---|
| Price | $187.41 | $46.96 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 22 |
| Target Price | ★ $146.91 | $93.18 |
| AVG Volume (30 Days) | 9.7M | ★ 21.9M |
| Earning Date | 04-28-2026 | 04-22-2026 |
| Dividend Yield | ★ 0.74% | N/A |
| EPS Growth | ★ 215.52 | 55.20 |
| EPS | 0.43 | ★ 0.90 |
| Revenue | ★ $15,629,000,000.00 | $9,076,000,000.00 |
| Revenue This Year | $20.74 | $11.85 |
| Revenue Next Year | $12.80 | $10.16 |
| P/E Ratio | $417.21 | ★ $52.12 |
| Revenue Growth | ★ 19.14 | 12.49 |
| 52 Week Low | $49.97 | $45.99 |
| 52 Week High | $211.79 | $109.50 |
| Indicator | GLW | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 52.67 | 28.30 |
| Support Level | $171.11 | N/A |
| Resistance Level | $210.18 | $50.14 |
| Average True Range (ATR) | 11.77 | 1.51 |
| MACD | -1.85 | 0.03 |
| Stochastic Oscillator | 50.20 | 12.41 |
Corning is a provider of glass, ceramics, and optical fiber across six distinct end markets. Corning's largest segments by revenue are display glass for TVs and optical fiber for telecom networks and data centers. It also provides cover glass for smartphones as well as filters and substrates and glass for cars, produces pharmaceutical glass, and produces polysilicon for solar panels. Corning is a US producer and is vertically integrated across its products and markets.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.